BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15939463)

  • 1. Endocannabinoid system and alcohol addiction: pharmacological studies.
    Colombo G; Serra S; Vacca G; Carai MA; Gessa GL
    Pharmacol Biochem Behav; 2005 Jun; 81(2):369-80. PubMed ID: 15939463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the cannabinoid CB1 receptor and alcohol dependence: preclinical evidence and preliminary clinical data.
    Maccioni P; Colombo G; Carai MA
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):55-9. PubMed ID: 20201816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressing effect of the cannabinoid CB1 receptor antagonist, SR 141716, on alcohol's motivational properties in alcohol-preferring rats.
    Colombo G; Vacca G; Serra S; Carai MA; Gessa GL
    Eur J Pharmacol; 2004 Sep; 498(1-3):119-23. PubMed ID: 15363985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid-induced increase in relapse-like drinking is prevented by the blockade of the glycine-binding site of N-methyl-D-aspartate receptors.
    Alén F; Santos A; Moreno-Sanz G; González-Cuevas G; Giné E; Franco-Ruiz L; Navarro M; López-Moreno JA
    Neuroscience; 2009 Jan; 158(2):465-73. PubMed ID: 18977415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats.
    Rubio M; Fernández-Ruiz J; de Miguel R; Maestro B; Michael Walker J; Ramos JA
    Neuropharmacology; 2008 May; 54(6):976-88. PubMed ID: 18371990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine.
    Vlachou S; Stamatopoulou F; Nomikos GG; Panagis G
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):905-23. PubMed ID: 18377702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling.
    Fukudome Y; Ohno-Shosaku T; Matsui M; Omori Y; Fukaya M; Tsubokawa H; Taketo MM; Watanabe M; Manabe T; Kano M
    Eur J Neurosci; 2004 May; 19(10):2682-92. PubMed ID: 15147302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological activation of CB1 and D2 receptors in rats: predominant role of CB1 in the increase of alcohol relapse.
    Alen F; Moreno-Sanz G; Isabel de Tena A; Brooks RD; López-Jimenez A; Navarro M; López-Moreno JA
    Eur J Neurosci; 2008 Jun; 27(12):3292-8. PubMed ID: 18554293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol inhibits spontaneous activity of basolateral amygdala projection neurons in the rat: involvement of the endocannabinoid system.
    Perra S; Pillolla G; Luchicchi A; Pistis M
    Alcohol Clin Exp Res; 2008 Mar; 32(3):443-9. PubMed ID: 18215217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats.
    Colombo G; Serra S; Brunetti G; Gomez R; Melis S; Vacca G; Carai MM; Gessa L
    Psychopharmacology (Berl); 2002 Jan; 159(2):181-7. PubMed ID: 11862347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference.
    Hansson AC; Bermúdez-Silva FJ; Malinen H; Hyytiä P; Sanchez-Vera I; Rimondini R; Rodriguez de Fonseca F; Kunos G; Sommer WH; Heilig M
    Neuropsychopharmacology; 2007 Jan; 32(1):117-26. PubMed ID: 16482090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression by baclofen of the stimulation of alcohol intake induced by morphine and WIN 55,212-2 in alcohol-preferring rats.
    Colombo G; Serra S; Vacca G; Gessa GL; Carai MA
    Eur J Pharmacol; 2004 May; 492(2-3):189-93. PubMed ID: 15178364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system.
    Pfitzer T; Niederhoffer N; Szabo B
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):9-17. PubMed ID: 15660243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
    Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
    Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.
    Melis M; Pistis M; Perra S; Muntoni AL; Pillolla G; Gessa GL
    J Neurosci; 2004 Jan; 24(1):53-62. PubMed ID: 14715937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat.
    Spano MS; Fattore L; Cossu G; Deiana S; Fadda P; Fratta W
    Br J Pharmacol; 2004 Oct; 143(3):343-50. PubMed ID: 15339858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent ethanol consumption depresses endocannabinoid-signaling in the dorsolateral striatum of rat.
    Adermark L; Jonsson S; Ericson M; Söderpalm B
    Neuropharmacology; 2011 Dec; 61(7):1160-5. PubMed ID: 21251919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
    Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
    J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids.
    Hentges ST; Low MJ; Williams JT
    J Neurosci; 2005 Oct; 25(42):9746-51. PubMed ID: 16237178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
    Solinas M; Goldberg SR
    Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.